Sinopharm Schedules 18 June 2026 AGM to Vote on 2025 Dividend, Auditor Re-appointments and New Capital Mandates

Sinopharm Group Co. Ltd. will convene its 2026 annual general meeting (AGM) at 09:00 a.m. on 18 June 2026 in Shanghai (Meeting Room 1401, Sinopharm Group Building, No. 385 East Longhua Road, Huangpu District).

Key resolutions to be put before shareholders include:

• 2025 Operating and Supervisory Reports – Consideration of the Board of Directors’ and Supervisory Committee’s reports for the year ended 31 December 2025.

• 2025 Financial Statements and Dividend Proposal – Approval of the audited consolidated financial statements and auditors’ report for FY 2025. – Approval of the 2025 profit-distribution plan and payment of a final dividend (amount not disclosed in the proxy statement).

• Remuneration Authorisations – Empower the Board to set remuneration for directors and the Supervisory Committee to set remuneration for supervisors for FY 2026.

• Auditor Re-appointments – Re-appointment of Confucius International CPA Limited as international auditor and Pan-China Certified Public Accountants LLP as domestic auditor until the next AGM, with remuneration to be confirmed by the Board’s audit committee.

• Guarantee Limit Mandate – Authorisation for the Board to provide guarantees for subsidiaries up to 30% of the Company’s latest audited total assets during the 12-month period following AGM approval, subject to Hong Kong Listing Rule requirements.

Special resolutions:

• General Share Issuance Mandate – Grant the Board a general mandate to allot, issue and/or deal with Domestic Shares and/or H Shares and to sell or transfer any treasury shares.

• H-Share Repurchase Mandate – Grant the Board a general mandate to repurchase H Shares.

• Extension of Debt-Financing Registration Validity – Extend the validity period of the registration notice for the Company’s non-financial corporate debt-financing instruments.

Shareholders of registered Domestic and H shares (face value RMB1.00 each) may appoint proxies to attend and vote. Proxy forms and, where applicable, notarised powers of attorney must reach the Company’s Hong Kong H-share registrar or the Shanghai head office no later than 24 hours before the meeting. The AGM is expected to conclude within half a day, and attendees must present valid identification.